  Dual-energy CT ( DECT) is an emerging technology that has potential to enhance diagnostic performance and radiologists ' confidence in the evaluation of thoracic malignancies. DECT clinical applications include characterization of solitary pulmonary nodule<disease> , lung masses and mediastinal tumors. DECT-derived iodine uptake quantification may assist in characterization of tumor differentiation and gene expression. The use DECT in oncology has potential to improve lung cancer staging , therapy planning , and assessment of response to therapy as well as detection of incidental pulmonary embolism.